Free Trial

Health Sciences Acquisitions Co. 2 (HSAQ) 10K Form and Latest SEC Filings 2026

Health Sciences Acquisitions Co. 2 logo
$4.01 -0.01 (-0.25%)
As of 05/5/2026

Latest Health Sciences Acquisitions Co. 2 SEC Filings & Recent Activity

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) has submitted 284+ documents to the U.S. Securities and Exchange Commission (SEC) since 2020. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form SCHEDULE 13D/A submitted on April 29, 2026.

Form 4
Orchestra BioMed Holdings, Inc. Reports Ownership Change on Apr. 29, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-K
Health Sciences Acquisitions Co. 2 Files Annual Report on Mar. 12, 2026

The 10-K contains Health Sciences Acquisitions Co. 2's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Health Sciences Acquisitions Co. 2 SEC Filing History

Browse Health Sciences Acquisitions Co. 2's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/29/2026 4:37 PM
Health Sciences Acquisitions Co. 2 (1814114) Subject
RTW INVESTMENTS, LP (1493215) Filed by
Form SCHEDULE 13D/A
04/29/2026 4:36 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
RTW INVESTMENTS, LP (1493215) Reporting
WONG RODERICK (1493280) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:31 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form DEFA14A
04/29/2026 3:34 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form ARS
03/27/2026 3:30 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 3:30 PM
Aiello Joshua (1960418) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 3:31 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Sherman Darren (1723524) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 7:03 AM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2026 3:28 PM
Health Sciences Acquisitions Co. 2 (1814114) Subject
RTW INVESTMENTS, LP (1493215) Filed by
Form SCHEDULE 13D/A
02/06/2026 3:15 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Sherman Darren (1723524) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:15 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2026 3:15 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2026 3:16 PM
Cleary Chris (2054585) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 8:12 AM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2026 5:53 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Sherman Darren (1723524) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2026 5:54 PM
Aiello Joshua (1960418) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2026 5:55 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Taylor Andrew Lawrence (1723889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 3:15 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 3:17 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Taylor Andrew Lawrence (1723889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 3:05 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 424B3
11/19/2025 3:05 PM
Health Sciences Acquisitions Co. 2 (1814114) Subject
Tasso Partners, LLC (1965743) Filed by
Form SCHEDULE 13G
11/17/2025 4:00 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 7:30 AM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2025 4:01 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form S-3
Registration statement under Securities Act of 1933  
10/30/2025 6:30 AM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 7:12 AM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2025 5:57 PM
Aryeh Jason (1376960) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2025 4:30 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2025 4:30 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Taylor Andrew Lawrence (1723889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2025 4:31 PM
Aiello Joshua (1960418) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025 3:15 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Sherman Darren (1723524) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025 6:01 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Taylor Andrew Lawrence (1723889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025 6:03 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025 6:04 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Sherman Darren (1723524) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025 6:04 PM
Fain Eric S (1402222) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 7:00 AM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2025 6:18 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Taylor Andrew Lawrence (1723889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:09 PM
Aiello Joshua (1960418) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:10 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Pacitti David (1722733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:11 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:12 PM
Cleary Chris (2054585) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:12 PM
Fain Eric S (1402222) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:13 PM
Mack John Prosper (2031699) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:14 PM
Connealy Pamela Ann (1796310) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:15 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Sherman Darren (1723524) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025 6:17 PM
Aryeh Jason (1376960) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025 3:28 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
RTW INVESTMENTS, LP (1493215) Reporting
WONG RODERICK (1493280) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025 3:29 PM
Health Sciences Acquisitions Co. 2 (1814114) Subject
RTW INVESTMENTS, LP (1493215) Filed by
Form SCHEDULE 13D/A
08/05/2025 9:46 AM
EDELMAN JOSEPH (1164426) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
PERCEPTIVE ADVISORS LLC (1224962) Reporting
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (1249675) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2025 5:16 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2025 4:16 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 424B5
06/27/2025 4:09 PM
Aryeh Jason (1376960) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025 4:10 PM
Fain Eric S (1402222) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 4:15 PM
Fain Eric S (1402222) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 4:17 PM
Connealy Pamela Ann (1796310) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 4:19 PM
Mack John Prosper (2031699) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 4:20 PM
Cleary Chris (2054585) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 4:14 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Pacitti David (1722733) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 2:11 PM
Fain Eric S (1402222) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025 3:14 PM
Health Sciences Acquisitions Co. 2 (1814114) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025 3:41 PM
Hochman David P (1292834) Reporting
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025 3:43 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Taylor Andrew Lawrence (1723889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025 4:32 PM
Health Sciences Acquisitions Co. 2 (1814114) Issuer
Sherman Darren (1723524) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Health Sciences Acquisitions Co. 2 SEC Filings - Frequently Asked Questions

Health Sciences Acquisitions Co. 2 (HSAQ) has submitted 284+ filings to the SEC since 2020. You can browse the complete history or filter by form type using the tools above.

Health Sciences Acquisitions Co. 2's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form SCHEDULE 13D/A submitted on April 29, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:HSAQ) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners